ComKardia
Newton, US · Founded 2021
Biotech
Founders & leadership
IC
Ioannis ChatzizisisDirector
MK
Maria KyparissopoulouExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements▶$250KraisedSep 2022 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedSep 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ioannis ChatzizisisDirector
- Maria KyparissopoulouExecutive Officer, Director
- Offering amount
- $3.1M
- Amount sold
- $250K
- Proceeds to insiders
- $21K
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.